Total Visits

Views
Early ...36

Total Visits Per Month

June 2023July 2023August 2023September 2023October 2023November 2023December 2023
Early ...0000030

File Visits

Views
early_modulation_circulating_micrornas_levels_her2_positive_breast_cancer_patients_treated_trastuzumab_based_neoadjuvant_therapy_2020.pdf22
early_modulation_circulating_micrornas_levels_her2_positive_breast_cancer_patients_treated_trastuzumab_based_neoadjuvant_therapy_2020.pdf_llegenda_figures.pdf18
early_modulation_circulating_micrornas_levels_her2_positive_breast_cancer_patients_treated_trastuzumab_based_neoadjuvant_therapy_2020.pdf_figura1.pdf17
early_modulation_circulating_micrornas_levels_her2_positive_breast_cancer_patients_treated_trastuzumab_based_neoadjuvant_therapy_2020.pdf_figura2.tiff11
early_modulation_circulating_micrornas_levels_her2_positive_breast_cancer_patients_treated_trastuzumab_based_neoadjuvant_therapy_2020.pdf_figura4.pdf8
early_modulation_circulating_micrornas_levels_her2_positive_breast_cancer_patients_treated_trastuzumab_based_neoadjuvant_therapy_2020.pdf_figura3.pdf8
early_modulation_circulating_micrornas_levels_her2_positive_breast_cancer_patients_treated_trastuzumab_based_neoadjuvant_therapy_2020.pdf_taula1.pdf8

Top country views

Views
United States18
Canada4
Spain4
Germany2
Sweden2
Belgium1
Finland1
France1
Japan1
New Zealand1

Top cities views

Views
Ashburn6
Chicago6
Barcelona3
Beauharnois1
Brussels1
Chandler1
Columbus1
Des Moines1
Hamilton1
Helsinki1